OpenAlex
PricingAboutJobs
Log inGet started
Work

Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.

PubMed

Year: 2002
Type: article
Source: PubMed
Authors: Kai U Chow, Wolf Daniel Sommerlad, Simone Boehrer, Bernd Schneider, Gernot Seipelt, Mathias Johannes Rummel, Dieter Hoelzer, Paris S Mitrou, Eckart Weidmann
Institution: University Hospital Frankfurt
Language: English

Topic: Lymphoma Diagnosis and Treatment
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rituximab, CD20, non-Hodgkin lymphoma, chronic lymphocytic leukemia, B-cell lymphoma, chemosensitization, apoptosis, caspase-7, caspase-8, complement system, cytokines, interleukin-2, IL-4, interleukin-6, IL-13, GM-CSF, TNF-α, doxorubicin, mitoxantrone, cladribine, bendamustine
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1783223960
FWCI: 7.066
Cites: 18
Cited by: 202
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms